Brief: Ceapro Q4 Sales C$3.721 Million
16/04/2020 15:30
April 16 (Reuters) - Ceapro Inc CZO.V :
* CEAPRO REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS
AND
HIGHLIGHTS
* Q4 SALES C$3.721 MILLION VERSUS C$11.59 MILLION
Source text for Eikon: ID:nGNX3nPbQ2
Further company coverage: CZO.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases